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Abstract 
This paper describes the development of a tree-based decision model to predict the severity of pediatric 
asthma exacerbations in the emergency department (ED) at two hours following triage. The model was 
constructed from retrospective patient data abstracted from the ED charts. The original data was 
preprocessed to eliminate questionable patient records and to normalize values of age-dependent clinical 
attributes. The model uses attributes routinely collected in the ED and provides predictions even for 
incomplete observations. Its performance was verified on independent validating data (split-sample 
validation) where it demonstrated AUC (area under ROC curve) of 0.83, sensitivity of 84%, specificity of 
71% and the Brier score of 0.18. The model is intended to supplement an asthma clinical practice 
guideline, however, it can be also used as a stand-alone decision tool. 
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1. Introduction 
Asthma exacerbations are one of the most common medical reasons for children to be 
brought to the emergency department (ED). These visits, and subsequent hospitalizations 
required by many of these patients, account for nearly 65% of all direct costs of asthma care. 
Despite such prevalence, several studies demonstrate extensive variation in care provided to 
asthmatic patients in the ED [1, 2]. In an attempt to standardize care and improve patient 
outcomes [3], asthma clinical practice guidelines (CPGs) have been developed by national 
bodies [4, 5], however their clinical use is limited. This may be attributed to several problems 
common to CPGs developed for other clinical conditions, including their availability in a paper 
format that requires translation into a computer readable format [6] for better integration with a 
clinical workflow, and the need for customization to site-specific characteristics – this task alone 
constitutes up to 90% of the total implementation effort [7].  
Our research is concerned with customizing a pediatric asthma CPG to a local setting. 
More specifically, we aim at simplifying the use of the CPG by using available clinical attributes 
(signs, symptoms and tests) and by allowing incomplete information about patient’s state. Figure 
1 presents a general schema of the pediatric asthma CPG published by the Canadian Association 
of Emergency Physicians (CAEP) [5]. Although the schema delineates the specific CPG, it can 
be easily generalized for other pediatric asthma guidelines. It begins with a decision step where 
the severity of the exacerbation is evaluated. Then, for each possible outcome, a corresponding 
action step specifies how to manage the patient. Asthma CPGs usually have four levels of 
severity – the first three (mild, moderate and severe) correspond to situations managed in the ED 
and the last (near death) requires immediate hospitalization in the intensive care unit. Because of 
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the clinical specificity and rarity of patients in this last level, we focus on mild, moderate, and 
severe conditions only.  
A gap between the published CPG and local clinical practices or contexts intervenes 
mostly during the step of severity evaluation. We encountered this problem when trying to 
reconcile the decision criteria from the CAEP CPG with patient information collected at the test 
site (the ED at the Children’s Hospital of Eastern Ontario), where only two clinical attributes 
referenced in the CPG were among those routinely collected. Thus, augmenting the severity 
evaluation by a decision model suited to the local setting seems to be crucial for successful 
utilization of the CPG. Action steps may also require customization by matching suggested 
treatments and management options with local resources and practices [7], however this is 
beyond the scope of our research. 
There has been extensive research on developing decision models (mostly in form of 
clinical scores or indexes) for pediatric asthma to help predict the severity of an exacerbation. 
Literature reviews identify more than sixteen such models [8, 9]. Examples include the Asthma 
Severity Scale (ASS) [10], Clinical Asthma Score (CAS) [11], Pediatric Asthma Severity Score 
(PASS) [12], Pediatric Respiratory Assessment Measure (PRAM) [13], and Pulmonary Score 
(PS) [14]. Unfortunately, they suffer from the same shortcomings as any asthma CPG – they rely 
on clinical attributes that are not routinely used or that cannot be collected for all patients (e.g., 
results of pulmonary function tests that are applicable to older children [15]) and require 
complete information characterizing the patient’s state. 
Due to these limitations we decided to develop a new decision model for predicting the 
severity that relies on clinical data collected at the local setting and is more flexible in terms of 
input requirements (it works with information limited to what physicians have deemed necessary 
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in given circumstances). We followed a discovery-driven approach to model development [16] 
and created it from retrospective chart data. We preprocessed the data to take into account the 
existence of missing values, inconsistent categorizations, and contextual dependencies between 
values of some of the attributes. Then we applied machine learning to construct a tree-based 
decision model from the preprocessed data. The format of a decision tree is common for 
representing clinical algorithms, and thus familiar for physicians and relatively easy to interpret 
[17, 18].  
The proposed decision model is intended to be used around two hours after starting the 
ED management process, which is consistent with other asthma studies [19-21] reporting that the 
results of post-treatment assessments have better predictive capabilities. Following discussions 
with ED physicians we collapsed the original severity levels into binary classes of mild and 
moderate/severe because of the clinical importance of early differentiation between the relatively 
benign condition (mild) and the others (moderate/severe), which require more aggressive 
intervention. According to clinical practice, both moderate and severe patients should receive 
systemic steroids, while mild patients should not. Evidence demonstrates that early 
administration of steroids results in earlier discharge of the patient [22], hence, early and 
accurate identification of moderate/severe patients in the ED should improve patient outcomes 
and operational efficiencies. Other differences in management (e.g., anticholinergics) between 
moderate and severe patients have less impact on the clinical outcome of the patient.  
The paper is organized as follows. In Section 2 we describe the retrospective chart study 
and the process of developing and validating our decision model with focus on data 
preprocessing. In Section 3 we give a description of the analysis including the characteristic of 
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the collected data, the structure of the developed model and the results of its validation. Finally, 
we conclude with a discussion in Section 4. 
2. Materials and Methods 
2.1. Study Setting and Population 
This study was conducted at the Children’s Hospital of Eastern Ontario (CHEO) (Ottawa, 
Ontario, Canada). CHEO is a tertiary-care pediatric teaching hospital affiliated with the 
University of Ottawa serving patients up to 18 years of age. The ED has 53,000 annual patient 
visits (approximately 2,800 of them are visits for asthma – 2005/06 data) and is staffed 24-hours 
per day by specialty-trained Pediatric Emergency Medicine physicians along with fellows, 
residents and medical students.  
Asthma management at CHEO includes a critical pathway [23] that outlines the 
standardized assessments and treatments patients should undergo to achieve sufficient reduction 
in respiratory distress prior to discharge home. The pathway is used as the primary nursing 
documentation tool and becomes part of the patient record. Medical directives are in place 
allowing the triage nurse to initiate bronchodilator treatments prior to physician assessment, and 
preprinted order sheets facilitate further treatment and investigation orders by physicians 
conforming to best evidence. 
Records from children 1-17 years of age presenting to the ED between November 1, 2000 
and July 30, 2004 for an asthma exacerbation were initially identified from ICD-10 coded 
discharge diagnoses. The study was approved by the CHEO Research Ethics Board. 
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2.2. Data Abstraction 
A trained data abstractor reviewed each identified asthma visit using standardized 
inclusion and exclusion criteria (Table 1). When a patient had multiple asthma visits, index visits 
were identified as the first visit for an exacerbation, with the requirement that this exacerbation 
be distinctly unique using a two-month washout period from prior exacerbations documented.  
For each index visit, the abstractor collected values of clinical attributes describing past 
history, history of current exacerbation, triage assessment, repeated assessments and final 
disposition. The complete list of collected attributes is given in Table 2.  
Finally, the data abstractor, in consultation with one of the investigators (KF), assigned 
each visit to one of three groups (mild, moderate and severe) using the duration of the visit and 
presence of relapse visits as a proxy, according to strict, pre-defined criteria. This allowed us to 
identify those cases where the initial discharge decision was premature (e.g., the patient was 
incorrectly discharged and required another ED visit within a few days) and to change the 
severity assignment accordingly. Then the moderate and severe categories were collapsed 
together into the moderate/severe one, and we used this final severity assignment (mild or 
moderate/severe) as the gold standard (a correct decision that was or should have been made) 
when evaluating performance of the decision models. 
2.3. Model Development 
2.3.1. Experimental Design 
The design of the experiment to develop a tree-based decision model is given in Figure 2. 
It follows a design presented in [24], where the authors described the process of developing and 
validating a tree-based decision model to identify high-risk elderly intensive care unit patients. 
According to this design, a data set is partitioned into developmental and validation sets. The 
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developmental set is used to identify the best decision model in 10-fold cross validation process 
and the validation set is applied to validate the performance of a selected model. 
Our experiment started with attribute filtering where from the list given in Table 2 we 
excluded attributes with a significant number of missing values – because of the retrospective 
nature of data abstraction process we were not able to conclude about the reasons for missing 
values and to impute them (e.g., with “normal” or “typical” values). 
In step 2 the entire data set was partitioned into the developmental and validation sets 
according to the date of visit – records corresponding to visits before a selected date were 
included in the developmental set, and the remaining records were assigned to the validation set. 
This allowed us to mimic clinical practice, where a model would be constructed from data 
collected up to a certain point, and verified afterwards. Such an approach, being a special case of 
split-sample validation, has resulted in realistic validation of a decision model. 
After partitioning the data we proceeded to find the best tree-based decision model (steps 
3 – 6). As stated in [25] identification of the best decision model “is conceptually a search 
process: the algorithms used for their construction are searching a model space for the model that 
is most appropriate”. In our research we used the C4.5 algorithm [26] implemented in the 
WEKA system [27] to construct decision models. The search space was defined by considering 
different approaches to preprocessing of the data and various complexity levels of potential 
decision models.  
The C4.5 algorithm follows the divide-and-conquer approach to decision tree induction. 
It recursively partitions the data into subsets according to splits defined by attributes and their 
values. For nominal attributes splits correspond to all their possible values and for numeric 
attributes only two-way (or binary) splits based on a certain threshold value are considered. To 
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select the best split, the algorithm uses two measures based on entropy – the information gain 
and the gain ratio. A split is selected if it maximizes the gain ratio, providing its information gain 
is above the average for all considered splits to compensate for highly branching splits that may 
have been favored by the gain ratio. The partitioning process stops if the data cannot be split any 
further. 
In order to deal with missing values C4.5 does not introduce any additional specialized 
splits (like surrogate splits in CART [28]). Instead records where the value of the splitting 
attribute is missing are fragmented into so-called fractional records [29]. Fractional records are 
proportionally distributed among outcomes of a split (i.e., outgoing branches) using a weighting 
schema that is based on the number of learning records with known values that followed each 
branch. During construction of a tree, these fractional records are included in computing 
information gain and gain ratio when selecting subsequent splits. During classification of an 
unseen record with missing values, fractional records are used to calculate a class probability 
distribution, and then the most probable class is selected as the predicted one. 
A tree constructed by recursive partitioning is very likely to overfit the learning data, and 
thus to perform poorly on unseen records. To address this problem C4.5 uses postpruning. After 
growing a full tree it checks specific splitting nodes from the bottom up and decides whether 
they should be postpruned (replaced by a leaf node or raised up) or not. The decision is made on 
the basis of estimated error rate – a node is postpruned if it leads to a lower estimate. The extent 
to which a tree is pruned is controlled by the confidence factor – a parameter that translates into 
confidence limits used to estimate the error rate. The default value for the confidence factor is 
25% and decreasing it results in more aggressive pruning and a smaller size (in terms of the 
number of nodes) of a tree.  
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Possible decision models were constructed and evaluated in steps 3 – 6. As it is normally 
accepted, we used the 10-fold cross validation (10-fcv) schema. The developmental set was 
randomly split into 10 mutually exclusive subsets. Nine subsets were then combined into a 
learning set used to construct a decision model, and the 10th subset was used to evaluate the 
performance of the model. This was repeated 10 times, so each of the subsets was used once for 
testing and 9 times for learning. For more reliable estimates of performance we repeated 10-fcv 
10 times [27] using a different random seed to split the developmental set in each run of cross 
validation, and we averaged the obtained 100 evaluations to get the final estimates. 
In step 3 we preprocessed learning sets to address their undesirable characteristics that 
may have negatively impacted the quality of constructed models. We dealt with incompleteness, 
inconsistent categorizations and contextual dependencies between attributes (all these problems 
are common in medical data [30]). Specifically, we filtered questionable patient records and 
contextually normalized age-dependent attributes – the applied techniques are described in 
details in Section 2.3.2 and 2.3.3, respectively. In order to assess the effect of each of these two 
techniques on the performance of constructed models, we followed the concept of a factorial 
experiment, with the two binary factors corresponding to the use of two preprocessing 
techniques.  
In step 4 we used the C4.5 algorithm to construct four possible tree-based decision 
models. They were built for a reduced number of attributes (as we indicated in the beginning, 
attributes with significant number of missing values were excluded from the analysis) and using 
contextually normalized values of selected attributes, where applicable. The models, labeled M1 
to M4, corresponded to alternative preprocessing options applied in step 3 and are briefly 
characterized in Table 3. We controlled the complexity of these models by changing values of 
10 
the confidence factor from 25% to 1% - such range followed the suggestion from [31] and it 
resulted in models of decreasing sizes. 
In step 5 possible decision models were evaluated on the testing sets by comparing their 
predictions to the gold standard. During evaluation we considered two performance measures – 
area under Receiver Operating Characteristics (ROC) curve (AUC) [32] and sensitivity (for the 
cut-off of 0.5). AUC represents the probability that a decision model will rank a randomly 
chosen record from the critical (positive) category higher than a randomly chosen negative 
instance [33]. When computing these measures we considered moderate/severe to be a positive 
category (critical class), and mild to be a negative one. 
In step 6 we computed the final estimates of performance and selected the best model that 
maximized AUC (primary criterion) and sensitivity (secondary criterion). We focused on the 
measures characterizing the discriminative abilities of a model as it was in line with the overall 
goal of our research – early differentiation between mild and moderate/severe patients. 
Finally, in step 7 the best model selected in the previous step was recreated using the 
entire developmental set and it was validated using the validation set. To better characterize its 
predictive performance we expanded the set of performance measures to include overall 
accuracy, specificity, positive predictive value (PPV), negative predictive value (NPV), all 
computed for the cut-off of 0.5, and the Brier score, computed as the mean of the squared errors 
of the probability predictions [24]. The latter is a measure of calibration and thus it complements 
AUC, which is a measure of discrimination. 
2.3.2. Record Filtering 
Record filtering was inspired by research showing the positive impact of removing 
records with missing values on the prediction performance [34, 35]. Instead of using a simple 
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record deletion technique [36] we employed expert knowledge to find “questionable” records. 
We used the PRAM score [13] as a proxy for such knowledge. PRAM is an evaluative score that 
uses 5 clinical attributes (suprasternal retractions, scalene contraction, air entry, wheezing and 
oxygen saturation) to derive an evaluation on a 12-point scale. Although it could not be applied 
directly to our data, with help of an emergency physician (KF) we developed a set of mapping 
rules to compute scores for 4 out of 5 attributes considered in PRAM. These rules were then 
applied to calculate so-called “modified” PRAM (M-PRAM) scores. Since triage (pre-treatment) 
assessments are reported to be not correlated with patient outcome [21], we applied M-PRAM to 
repeated (post-treatment) assessments.  
The rules for calculating M-PRAM are listed in Table 4. One of the rules corresponding 
to wheezing indicates invalid combination of values – in such case M-PRAM cannot be 
computed. Moreover, two rules corresponding to air entry rely on the severity category limiting 
the applicability of M-PRAM to retrospective data only.  
We labeled a record to be “questionable” if it was impossible to compute M-PRAM 
(because of missing values or their invalid combinations) or if a record associated with 
moderate/severe exacerbation received M-PRAM score equal to 0 (while it should be 4 or more 
[13]). The latter allowed us to exclude those records, where the final outcome was clearly 
inconsistent with recorded findings. We decided not to filter records associated with mild 
exacerbations even if they had high M-PRAM scores because the misclassification from mild to 
moderate/severe is a less serious mistake than misclassification in the opposite direction.  
2.3.3. Contextual Normalization 
The retrospective data included four context-sensitive attributes – heart rate and 
respiratory rate checked during triage and repeated assessments (TRI_HEART_RATE, 
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TRI_RESP_RATE, REP_HEART_RATE and REP_RESP_RATE, respectively). Each of these attributes 
had to be considered in the context of the patient’s age (REG_AGE), e.g., triage respiratory rate of 
28 was normal for a 2-year-old, but abnormal for a 7-year-old. Usually values of such attributes 
are normalized according to approved medical norms for specific age groups. Such an approach 
was used in ASS [10], however reported results were not satisfactory. 
In our analysis we used a data-driven normalization [37], where values of attributes were 
normalized using baseline values observed in the same context in a data set. In order to do so we 
took the mild category as the baseline and for each normalized record we identified records of 
mild patients with the most similar age (in other words, the nearest “mild neighbors” according 
to age). In our experiment we considered the size of the baseline neighborhood ranging from 5 to 
9, which was inspired by results from [37]. For the nearest baseline neighbors we calculated 
mean values and standard deviations (SD) for the four context-dependent attributes and used 
them in the following formula (where the raw value denotes a value before normalization) to 
calculate their normalized values:  
normalized value = (raw value – mean)/SD.  
Thus, a normalized value measures a relative difference between a raw value for a normalized 
record and a mean value for mild records in the same age group.  
Finally, we removed the age attribute from normalized records because it became 
redundant. Moreover, age alone is not a good predictor of the severity of asthma exacerbation 
[38]. 
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3. Results  
3.1. Collected Data 
During the retrospective chart study we extracted information from 775 index visits of 
341 patients with asthma exacerbations. They were used to develop the initial data set composed 
of 362 records. The number of records was smaller than the number of index visits because 
records were created only for those visits that had a documented repeated assessment at 2 hours 
± 20 minutes after triage (i.e., between 100 and 140 minutes). The basic characteristics of the 
initial data set, including descriptions of the developmental and validation sets are presented in 
Table 5. 
As expected, the majority of records were incomplete. Although all attributes transcribed 
from paper charts appear on the emergency triage assessment record and the critical pathway 
used in the ED, many of them were not consistently recorded. Information about missing values 
is given in Table 6. Ten attributes that had more than 50% of missing values were excluded from 
the analysis, thus it was conducted on data described with 32 attributes. Although the usefulness 
of attributes with more than 15% of missing values is reported to be questionable [36], setting a 
lower threshold would have resulted in removing too much information from the data. 
We used the date of October 1, 2003 to partition the data set into the developmental 
(prior) and validation (after) parts. Selecting this date allowed us to include in the validation set 
records of visits from fall and winter when usually the number of asthma exacerbations 
increases, especially for the youngest age group (1-4 years) [39].  
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3.2. Developed Model 
To develop a tree-based decision model we followed the process described in Section 
2.3.1. We successfully completed steps 1 –5, however, in step 6 we were not able to confidently 
select the best model. Table 7 lists evaluation results for the best decision models indentified in 
step 6 and corresponding to four data preprocessing options. The table also includes values of 
parameters controlling the contextual normalization (where applicable) and the complexity for 
resulting models. The estimates of AUC for all identified models were very close – the paired t-
test with confidence level of 1% conducted on results of 10-fcv runs revealed no statistical 
differences among them. Therefore, we used estimates of sensitivity as the secondary criterion 
for selection. The highest sensitivity was observed for M3 and M4 models, and the paired t-test 
confirmed that the sensitivity estimates for M3 and M4 were statistically different from the 
estimates for M1 and M2, and that there were no statistical differences between the sensitivity 
estimates for M3 and M4. Thus, we selected these two models for further validation.  
In step 7 we recreated the M3 and M4 models with controlling parameters identified in 
step 6 using the entire developmental set, and then we validated these models on the validation 
set. The results of validation are reported in Table 8. For all presented performance measures we 
constructed 95% confidence intervals (95% CI). CI for the Brier score was calculated using a t-
value assuming normal distribution of the score [40], CI for AUC was calculated using the 
bootstrap percentile method [41] and for sensitivity, specificity, PPV, NPV and accuracy we 
used the Wilson’s method [24]). 
The M4 model turned out to be superior to M3 and its AUC surpassed the desired level of 
0.8 [42] thus it was selected as the model for predicting severity of pediatric asthma 
exacerbations. The model is presented graphically in Figure 3. Its structure in terms of most 
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discriminatory conditions is supported by [8, 19], where the relevance of wheezing and 
retractions for predicting asthma severity was emphasized. The model uses normalized heart rate 
and respiratory rate recorded during the repeated assessment (REP_HEART_RATE and 
REP_RESP_RATE), which further amplifies a good correlation between post-treatment assessments 
and the predicted clinical outcome [20, 21]. It also utilizes information about prior assessment in 
the chest clinic (CHEST_CLINIC). The numbers in the leaf nodes indicate how many records from 
the developmental set were captured in these nodes. The first number shows the total number of 
records captured by a node, while the second corresponds to the number of misclassified records 
(i.e., records for which the category was different than the one indicated in the node). Fractional 
numbers result from the way the C4.5 algorithm handles missing values (i.e., from introducing 
fractional records). 
The M4 model includes attributes from the asthma clinical pathway that are routinely 
collected in the ED. Considering physicians’ familiarity with these attributes this model should 
be easy to understand and interpret. Moreover, as physicians need to manage asthmatic patients 
according to the clinical pathway, the use of the M4 model does not force physicians to collect 
additional patient data. 
To further evaluate the reported results we also constructed a logistic regression model 
using the developmental set and validated it on the validation set. Its performance, reported in 
Table 8, was worse than the performance of the M4 model on all measures (Figure 4 presents 
ROC curves for both models).  
4. Discussion 
The goal of our research was to customize asthma CPG by including site-specific 
information. We achieved this by proposing a new decision model for predicting the severity of 
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exacerbation that relies on locally available information and provides predictions in the absence 
of some values. The model is intended to be used at 2 hours after triage and distinguishes 
between mild and moderate/severe exacerbations that correspond to two major treatment options.  
Considering that learning about decision trees is a decision-making component of 
medical curriculum, a decision tree model generated from data is familiar construct for the 
physicians [17, 18]. Moreover, positive experience with tree-based models for diagnosing asthma 
and predicting hospital admission for asthmatic patients was reported by others [18, 43], who 
evaluated different decision models discovered from data (neural networks, linear discriminant 
functions, logistic regression). 
Bishop et al. [10] and Chey et al. [38] also created models to predict severity of asthma 
exacerbations and reported predictive performance of their models. We were not able to compare 
our model with their results because of data incompatibilities and different ways of measuring 
the model’s predictive performance. We used an objectively verified gold standard while 
calculating sensitivity and specificity (84% and 71% respectively), while ASS developed by 
Bishop et al. [10]  (when tested on the developmental data) had sensitivity of 97% and specificity 
of 50% in comparison to physicians’ predictions (such predictions should not be considered to be 
a gold standard). The logistic regression model proposed by Chey et al. [38] was tested on a 
validating hold-out sample but its sensitivity and specificity (88% and 89% respectively) were 
also calculated in comparison to physicians’ predictions. 
To address undesirable characteristics of the retrospective data we used two 
preprocessing techniques – filtering questionable records identified with help of M-PRAM and 
contextual normalization of age-sensitive attributes. All possible combinations in factorial design 
were evaluated using multiple runs of 10-fold cross validation. The model developed from the 
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data preprocessed with a help of both techniques demonstrated the best performance when 
validated on the independent validation set. It is worth noting that good performance was 
observed despite some of the inputs being incomplete (some attributes used by our model, e.g., 
REP_HEART_RATE or REP_RESP_RATE, had more than 30% missing values in the validation set). 
Our research has some limitations. First, we were able to conduct only a retrospective 
evaluation. A more complete evaluation should also include comparing the performance of the 
model with prediction performance of ED physicians on the same validation set (the quasi-
Touring test [44]). Unfortunately, we were not able to extract required physicians’ information 
(severity prediction at 2 hours) from charts and it was unrealistic to ask busy ED physicians to 
analyze more than 100 validation records. Another limitation results from the fact that our 
decision model relies on subjective attributes, i.e., wheezing or retractions (they are often 
referred to as “soft” clinical data [45]). Thus, in order to assess their variability we should have 
analyzed inter-observer agreement as suggested in [8]. However, such analysis was not possible 
in a retrospective chart study. Finally, the analyzed data set has a limited size (362 records) what 
may have limited the generality of the constructed decision model and the results of its 
validation. 
Despite these limitations, the results of our research can be generalized. We demonstrated 
that it is possible to develop a good customized predictive decision model from messy clinical 
data, provided that it has been preprocessed. Since the model relies on locally collected and 
available clinical information and is flexible in terms of input requirements, it should facilitate 
the routine use of a CPG. If necessary, our model can be also used as a standalone decision tool. 
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Figure 1. General schema of the CAEP CPG 
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Figure 2. General experimental design 
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Figure 3. The structure of the M4 model 
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Table 1. Inclusion and exclusion criteria for retrospective chart study 
Inclusion criteria 
1. Patient age between 1 and 17 years. 
2. Pre-existing diagnosis of asthma or reactive airways disease, as reported to the triage nurse or 
physician. Patients must have been previously prescribed inhaled bronchodilator therapy for at 
least one previous episode of wheeze, cough, or shortness-of-breath. 
3. Presenting complaint of wheeze, cough, shortness-of-breath, or difficulty breathing requiring 
bronchodilator therapy in the ED with an ED discharge diagnosis or inpatient admission 
diagnosis of asthma or reactive airways disease. 
Exclusion criteria 
1. Patients receiving oral steroids chronically for asthma or any other illness 
2. Patients receiving oral steroids for more than 48 hours prior to their ED visit for an acute 
exacerbation. 
3. Patients with co-existing pulmonary conditions, cardiac illnesses, gastroesophageal reflux, 
chronic aspiration, or neuromuscular disease. 
4. Patients presenting for medication refills or other non-urgent reasons related to asthma, and not 
requiring ED treatment. 
5. Patients diagnosed with bronchiolitis 
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Table 2. Attributes transcribed from charts 




1 Age at registration  REG_AGE numerical (years) 
2 Primary care PRIM_CARE family doctor, pediatrician, other, none 
3 Previous assessment in chest 
clinic 
CHEST_CLINIC yes, no 
4 Current inhaled steroids CURR_INH_STEROID < 1 week, 1 – 4 weeks, ≥ 4 weeks, as 
necessary, none 
5 Age at first symptoms AGE_FIRST_SX numerical (years) 
6 Previous oral steroids PREV_ORAL_STEROID < 1 month, 1 – 3 months, 3 – 12 months, ≥ 
12 months, none 
7 Previous ED visits last year PREV_ED_LAST_YEAR 1 visit, 2 visits, 3 visits, ≥ 4 visits, none 
8 Previous admission PREV_ADM floor, ICU, none 
9 Smokers in environment ENV_SMOKE yes, no 
10 Dander in environment ENV_DANDER yes, no 
11 Carpets in environment ENV_CARPETS yes, no 
12 Allergies to environment ALLG_ENV yes, no 
13 Allergies to pets ALLG_PETS yes, no 
14 Allergies to food ALLG_FOOD yes, no 
15 History of atopy PTHX_ATOPY yes, no 
16 Family history of asthma FMHX_ASTHMA yes, no 
17 Allergy exposure ALLG_EXP yes, no 
18 URTI symptoms URTI_SX yes, no 
19 Fever FEVER yes, no 
20 Duration of symptoms DUR_ASTHMA_SX numerical (hours) 
21 Bronchodilators in the last 24h VENT_LAST_24H numerical 
22 Arrival to the ED ARRV_ED ambulance, parents 
 Triage assessment   
23 Temperature TRI_TEMP numerical (Celsius degrees) 
24 Respiratory rate TRI_RESP_RATE numerical (breaths per minute) 
25 Heart rate TRI_HEART_RATE numerical (bits per minute) 
26 Oxygen saturation TRI_SAO2 numerical (%) 
27 Air entry TRI_AIR_ENTRY good, reduced 
28 Distress TRI_DISTRESS none, mild, moderate, severe 
29 Skin color TRI_COLOR pink, pale, dusky 
30 Expiratory wheeze TRI_EXP_WHEEZE present, absent 
31 Inspiratory wheeze TRI_INSP_WHEEZE present, absent 
32 Retractions TRI_RETRACTIONS present, absent 
 
Repeated assessment   
33 Temperature REP_TEMP numerical (Celsius degrees) 
34 Respiratory rate REP_RESP_RATE numerical (breaths per minute) 
35 Heart rate REP_HEART_RATE numerical (bits per minute) 
36 Oxygen saturation REP_SAO2 numerical (%) 
37 Air entry REP_AIR_ENTRY good, reduced 
38 Distress REP_DISTRESS none, mild, moderate, severe 
39 Skin color REP_COLOR pink, pale, dusky 
40 Expiratory wheeze REP_EXP_WHEEZE present, absent 
41 Inspiratory wheeze REP_INSP_WHEEZE present, absent 
42 Retractions REP_RETRACTIONS present, absent 
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Table 3. Decision models 
  Record filtering 
  No Yes 

















Yes M2 M4 
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Table 4. Expert rules for calculating M-PRAM 
PRAM attribute Conditions Score 
Suprasternal REP_RETRACTIONS = absent, REP_AIR_ENTRY = good 0 
retractions REP_RETRACTIONS = absent, REP_AIR_ENTRY <> good 1 
 REP_RETRACTIONS = present 2 
Air entry REP_AIR_ENTRY = good 0 
 REP_AIR_ENTRY = reduced, category = mild 1 
 REP_AIR_ENTRY = reduced, category = moderate/severe 3 
Wheezing REP_EXP_WHEEZE = absent, REP_INSP_WHEEZE = absent 0 
 REP_EXP_WHEEZE = absent, REP_INSP_WHEEZE = present invalid 
 REP_EXP_WHEEZE = present, REP_INSP_WHEEZE = absent 1 
 REP_EXP_WHEEZE = present, REP_INSP_WHEEZE = present 2 
Oxygen SaO2 >= 95% 0 
saturation 92% <= SaO2 <= 94% 1 
 SaO2 < 92% 2 
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Table 5. Characteristics of the data sets 
 Entire set Developmental set Validation set 
Category Records [n] Records [%] Records [n] Records [%] Records [n] Records [%] 
Mild 163 45.0 98 41.0 65 52.8 
Moderate/severe 199 55.0 141 59.0 58 47.2 
Total 362 100.0 239 100.0 123 100.0 
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Table 6. Missing values in the data set 
 Missing values [%] 
Code Entire set Developmental set Validation set 
REG_AGE 0.0 0.0 0.0 
PRIM_CARE 0.3 0.0 0.8 
CHEST_CLINIC 0.0 0.0 0.0 
CURR_INH_STEROID 41.4 37.7 48.8 
AGE_FIRST_SX 9.9 7.9 13.8 
PREV_ORAL_STEROID 13.8 15.5 10.6 
PREV_ED_LAST_YEAR 1.1 1.3 0.8 
PREV_ADM 1.4 1.7 0.8 
ENV_SMOKE 69.9 69.0 71.5 
ENV_DANDER 70.7 69.0 74.0 
ENV_CARPETS 83.7 83.3 84.6 
ALLG_ENV 1.7 1.7 1.6 
ALLG_PETS 1.4 1.3 1.6 
ALLG_FOOD 1.1 1.3 0.8 
PTHX_ATOPY 27.9 22.6 38.2 
FMHX_ASTHMA 23.2 20.9 27.6 
ALLG_EXP 74.0 74.5 73.2 
URTI_SX 3.3 2.9 4.1 
FEVER 9.7 9.6 9.8 
DUR_ASTHMA_SX 5.8 5.4 6.5 
VENT_LAST_24H 22.4 21.8 23.6 
ARRV_ED 1.4 1.3 1.6 
TRI_TEMP 20.7 22.6 17.1 
TRI_RESP_RATE 7.5 9.2 4.1 
TRI_HEART_RATE 1.7 2.1 0.8 
TRI_SAO2 1.7 2.1 0.8 
TRI_AIR_ENTRY 6.6 6.7 6.5 
TRI_DISTRESS 59.7 57.3 64.2 
TRI_COLOR 2.8 3.3 1.6 
TRI_EXP_WHEEZE 65.2 75.3 45.5 
TRI_INSP_WHEEZE 73.2 81.2 57.7 
TRI_RETRACTIONS 61.9 72.0 42.3 
REP_TEMP 85.6 87.9 81.3 
REP_RESP_RATE 22.7 17.2 33.3 
REP_HEART_RATE 25.4 19.2 37.4 
REP_SAO2 20.2 15.9 28.5 
REP_AIR_ENTRY 11.0 10.0 13.0 
REP_DISTRESS 90.3 91.6 87.8 
REP_COLOR 26.2 23.8 30.9 
REP_EXP_WHEEZE 14.6 13.0 17.9 
REP_INSP_WHEEZE 16.0 15.5 17.1 
REP_RETRACTIONS 16.9 15.9 18.7 
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Table 7. Evaluation results on the developmental set 
Measure M1 M2 M3 M4 
AUC ± SD 0.6464 ± 0.1209 0.6346 ± 0.1087 0.6477 ± 0.1301 0.6390 ± 0.1153 
Sensitivity ± SD [%] 73.76 ± 11.30 74.54 ± 12.11 78.00 ± 11.82 79.64 ± 11.71 
Tree size ± SD  11.6 ± 4.6 20.1 ± 8.0 17.7 ± 4.9 15.5 ± 5.3 
Confidence factor 5% 15% 15% 15% 
Number of baseline 
neighbors 
- 9 - 8 
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Table 8. Validation results for the M3 and M4 models and the logistic regression  
on the validation set (95% CI) 
Measure M3 M4 Logistic 
regression 




































Accuracy [%] 69.92 
(61.31; 77.32) 
77.24 
(69.07; 83.75) 
68.29 
(59.62; 75.86) 
 
 
